Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -287.31% is 119% below its 5-year average of -131.39%, near the low end of its 5-year range (-287.31%–-40.19%).
As of the fiscal period ended Wednesday, December 31, 2025. 57.70% below its 12-month average of -182.19%.
Annual fiscal-year return on equity; no daily interpolation. Historical series through 2025-12-31.
RETURN ON EQUITY (ROE)
-287.31%
RETURN ON EQUITY (ROE) AVG TTM
-182.19%
RETURN ON EQUITY (ROE) AVG 3Y
-117.96%
RETURN ON EQUITY (ROE) AVG 5Y
-131.39%
RETURN ON EQUITY (ROE) AVG 10Y
-4028.44%
RETURN ON EQUITY (ROE) AVG 15Y
-135.47%
RETURN ON EQUITY (ROE) AVG 20Y
-116.20%
CURRENT VS TTM AVG
-57.70%
CURRENT VS 3Y AVG
-143.57%
CURRENT VS 5Y AVG
-118.67%
CURRENT VS 10Y AVG
+92.87%
CURRENT VS 15Y AVG
-112.08%
CURRENT VS 20Y AVG
-147.25%
SECTOR MEDIAN · HEALTHCARE
-42.01%
median of 754 covered companies
CURRENT VS SECTOR MEDIAN
-583.91%
vs the sector median at left
SciSparc Ltd.
Market Cap
$242924.00
Return on Equity (ROE)
-287.31%
TTM Avg
-182.19%
3Y Avg
-117.96%
5Y Avg
-131.39%
Market Cap
$108729.00
Return on Equity (ROE)
-31722.73%
TTM Avg
-22.71%
3Y Avg
4.16%
5Y Avg
21.87%
Market Cap
$380715.00
Return on Equity (ROE)
-66.30%
TTM Avg
-86.35%
3Y Avg
-89.49%
5Y Avg
-12.24%
Market Cap
$381940.00
Return on Equity (ROE)
-5.89%
TTM Avg
-13.04%
3Y Avg
-24.95%
5Y Avg
-31.50%
Market Cap
$97282.00
Return on Equity (ROE)
N/A
TTM Avg
-12.94%
3Y Avg
110.91%
5Y Avg
74.52%
Market Cap
$71110.00
Return on Equity (ROE)
-56.04%
TTM Avg
-428.20%
3Y Avg
-266.31%
5Y Avg
-188.29%
Market Cap
$61495.00
Return on Equity (ROE)
N/A
TTM Avg
163.76%
3Y Avg
281.78%
5Y Avg
257.03%
Market Cap
$31083.00
Return on Equity (ROE)
-33.87%
TTM Avg
-18.48%
3Y Avg
-27.44%
5Y Avg
-15.83%
Market Cap
$30509.00
Return on Equity (ROE)
-124.31%
TTM Avg
-250.62%
3Y Avg
35.28%
5Y Avg
30.27%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| SciSparc Ltd. (SPRC) | $242924.00 | -287.31% | -182.19% | -117.96% | -131.39% |
| Silexion Therapeutics Ltd. (SLXN)vs › | $108729.00 | -31722.73% | -22.71% | 4.16% | 21.87% |
| Virax Biolabs Group Limited (VRAX)vs › | $380715.00 | -66.30% | -86.35% | -89.49% | -12.24% |
| Niki BioSolutions, Inc. (NIKI)vs › | $381940.00 | -5.89% | -13.04% | -24.95% | -31.50% |
| Psyence Biomedical Ltd. (PBM)vs › | $97282.00 | N/A | -12.94% | 110.91% | 74.52% |
| PRF Technologies Ltd. (PRFX)vs › | $71110.00 | -56.04% | -428.20% | -266.31% | -188.29% |
| Akanda Corp. (AKAN)vs › | $61495.00 | N/A | 163.76% | 281.78% | 257.03% |
| Zhongchao Inc. (ZCMD)vs › | $31083.00 | -33.87% | -18.48% | -27.44% | -15.83% |
| Mobile-health Network Solutions Class A Ordinary Shares (MNDR)vs › | $30509.00 | -124.31% | -250.62% | 35.28% | 30.27% |
| NewGenIvf Group Limited (NIVF)vs › | $6115.00 | N/A | 43.59% | 43.03% | 34.44% |
ROE
-287.3%
ROA
-159.8%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2025-12-31 | -287.31% |
| 2024-12-31 | -77.07% |
| 2023-12-31 | -67.27% |
| 2022-12-31 | -40.19% |
| 2021-12-31 | -71.26% |
| 2020-12-31 | -245.24% |
| 2019-12-31 | -38300.00% |
| 2018-12-31 | -4607.03% |
| 2017-12-31 | -76.82% |
| 2016-12-31 | -347.53% |
| 2015-12-31 | -193.14% |
| 2014-12-31 | 5039.86% |
| 2013-12-31 | 5.61% |
| 2012-12-31 | 178.51% |
| 2011-12-31 | -429.32% |
| 2010-12-31 | -110.08% |
| 2009-12-31 | -69.11% |
| 2008-12-31 | -62.83% |
| 2007-12-31 | -57.73% |
| 2006-12-31 | -24.65% |
